Currently the editor of "The Biotech Forum," Bret Jensen was chief investment strategist for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami, from 2008-2011. The fund was in the top 5% of long/short hedge funds for total return in its first full year (2009), as ranked by Hedgeco fund database (more than 450 funds in category). Prior to this, he spent a decade as technology director of a Fortune 100 firm.Expand

Jensen has been a top-5%-ranked financial analyst and blogger since 2013, according to TipRanks. He holds a Bachelor of Science degree in finance from Arizona State University.

Follow Bret on Twitter: @Bret_Jensen.Collapse

| Aug 25, 2016
| 1:32 PM EDT
Stocks continue to meander in very narrow ranges as investors appear hesitant to make any moves in front of to...
| Aug 25, 2016
| 11:01 AM EDT
Another listless day of trading with indices pretty much flatlined as investors await the latest words from Ch...
| Aug 24, 2016
| 11:10 AM EDT
Out in San Francisco for the Money Show and about to do presentation on biotech investing, but thought I would...
It was nice to fill in for Doug Kass on what was a very uneventful Monday to begin the week. The market traded in an extremely narrow range for the day, and outside the strength in biotech and the weakness in oil after a nice recent rally there really wasn't much of note that happened today. Still, there were some good conversations on the Daily Dairy despite the directionless market.
Markets continue to trade in a very narrow range and remain largely directionless.

Biotechs Rise and Oil Falls Real Money Pro($)

Foot Locker (FL) is getting a little lift after Citigroup tapped the footwear retailer as its top pick in retailing. Of course, the shares did move up more than 10% Friday on much-better-than-expected quarterly results. Biotechs continue their winning ways, although the sector is down slightly from its highs earlier in the day. Sorrento Therapeutics (SRNE) and
Stocks are back to flat to slightly lower overall, but biotechs are up some 1.5% following the announcement from Pfizer (PFE) of plans to buy Medivation (MDVN) for $14 billion.
Las Vegas Sands (LVS) continues to show strength after Bank of America/Merrill Lynch put out an optimistic note this morning about Macau gambling. Energy is weak in early trading. Oil has drifted back down to around $47 a barrel following its recent roughly 20% rally.

Bret's Morning Musings Real Money Pro($)

Futures show that the market looks to open slightly down to begin the new trading week. Oil is also trading down by some 2.5%, so energy companies could be weak today following their recent rally.

Bret Jensen Reporting for Duty Real Money Pro($)

Good morning, Bret Jensen here! It's good to be standing in for Doug Kass again on the daily diary as we begin a new trading week.

Columnist Conversations

We have followed all areas of the Healthcare industry for decades. And while there are likely many causes for ...
Shares of Dollar General (DG) got hammered today after fiscal Q2 EPS came in at $1.08 versus a $1.09 estimate....
Before the open today, I noted to our members that crude oil is starting to look and act like the correction o...
Stocks continue to meander in very narrow ranges as investors appear hesitant to make any moves in front of to...

BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.